Link: https://links.sgx.com/1.0.0/corporate-announcements/DUMIY9UMYP61F7IP/bebf15328afa121060d979abb84bae28edaeb0a2f726006f30828a0e02b2c1f9

Summary:

• 3Q 2025 revenue increased 9% YoY to $20.7 million, driven by higher patient visits and expanded specialised health services in Malaysia.

• Net profit for the quarter was $3.9 million, down 9% versus 3Q 2024 due to lower foreign exchange gains and higher administrative expenses.

• Gross profit rose 11% YoY, with margins improving to 43.9%.

• Nine-month revenue up 8% to $58.5 million; net profit marginally declined 2% from prior year.

• Administrative expenses increased due to new and expanded centres and higher staff costs.

• Construction progress for new Kuala Lumpur centre on track, with operations expected to commence by 2027.

• Myanmar operations remain operational and profitable, despite local political uncertainties.

• Group continues to pursue growth opportunities in Vietnam and Myanmar, alongside established Singapore and Malaysia markets.